Patient-derived 3D Tumour Organoid Models

Recent advances in the establishment of primary patient-derived tumour cell cultures hold great promise not only to improve our understanding of tumour biology, but also to significantly enhance the identification of truly individualised cancer therapies.

This is why we have partnered with cpo Cellular Phenomics & Oncology GmbH, a company that has meanwhile sourced and cultured more than 200 different patient-derived 3D tumour cell cultures, so-called PD3D® models.

Together with our collaborator cpo, we provide our clients with integrated compound testing & protein profiling services using cpo's proprietary PD3D® cell models.

We offer

  • Compound testing services in PD3D® models by cpo Cellular Phenomics & Oncology

  • Back-up of phenotypic compound testing data by cpo's NGS-based genomic profiling

  • Generation of comprehensive proteomic and phospho-proteomic signatures from PD3D® cultures (e.g., pre- vs post-treatment) via DigiWest or RPPA

Image of DigiWest in PD3D Tumor Cell Models


Please email us to learn more about our services.